Search research articles
Contact Us
Filters
Showing results (201-210 of 216) with videos related to
Page
of 22
Sort By:
Plos Neglected Tropical Diseases
|
June 16, 2023
Transmission-blocking activity of antimalarials for Plasmodium vivax malaria in Anopheles darlingi
Alice O Andrade, Najara A C Santos, Alessandra S Bastos, et al.
Plos Pathogens
|
July 2, 2026
Anti-malarial contact dependent blocking of transmission of Plasmodium vivax by Anopheles darlingi mosquito vector
Jéssica E A Kassupá, Alice O Andrade, Alessandra S Bastos, et al.
Microorganisms
|
May 4, 2026
Effectiveness of COVID-19 Vaccine Boosters in Children Across Pandemic and Endemic Periods
Eduardo A Oliveira, Maria Christina L Oliveira, Hercílio Martelli-Júnior, et al.
Medical Oncology (Northwood, London, England)
|
September 29, 2022
Transcription factor SOX3 upregulated pro-apoptotic genes expression in human breast cancer
Felipe Henrique de Souza Silva, Adam Underwood, Camila Pereira Almeida, et al.
Protein and Peptide Letters
|
August 16, 2021
Oral Angiotensin-(1-7) Peptide Modulates Intestinal Microbiota Improving Metabolic Profile in Obese Mice
Amanda Machado, Janaína Ribeiro Oliveira, Deborah de F Lelis, et al.
Scientific Reports
|
October 24, 2023
Optimization of Plasmodium vivax infection of colonized Amazonian Anopheles darlingi
Alice O Andrade, Najara Akira C Santos, Alessandra S Bastos, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
February 10, 2022
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients
Bruno Gualano, Carla G S Saad, Sofia M Sieczkowska, et al.
Rheumatology (Oxford, England)
|
May 31, 2022
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine
Nadia E Aikawa, Leonard V K Kupa, Clovis A Silva, et al.
The Lancet. Rheumatology
|
December 13, 2021
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study
Nadia E Aikawa, Leonard V K Kupa, Sandra G Pasoto, et al.
Nature Medicine
|
July 31, 2021
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial
Ana C Medeiros-Ribeiro, Nadia E Aikawa, Carla G S Saad, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 216) with videos related to
Sort By:
Page
of 22
Plos Neglected Tropical Diseases
|
June 16, 2023
Transmission-blocking activity of antimalarials for Plasmodium vivax malaria in Anopheles darlingi
Alice O Andrade, Najara A C Santos, Alessandra S Bastos, et al.
Plos Pathogens
|
July 2, 2026
Anti-malarial contact dependent blocking of transmission of Plasmodium vivax by Anopheles darlingi mosquito vector
Jéssica E A Kassupá, Alice O Andrade, Alessandra S Bastos, et al.
Microorganisms
|
May 4, 2026
Effectiveness of COVID-19 Vaccine Boosters in Children Across Pandemic and Endemic Periods
Eduardo A Oliveira, Maria Christina L Oliveira, Hercílio Martelli-Júnior, et al.
Medical Oncology (Northwood, London, England)
|
September 29, 2022
Transcription factor SOX3 upregulated pro-apoptotic genes expression in human breast cancer
Felipe Henrique de Souza Silva, Adam Underwood, Camila Pereira Almeida, et al.
Protein and Peptide Letters
|
August 16, 2021
Oral Angiotensin-(1-7) Peptide Modulates Intestinal Microbiota Improving Metabolic Profile in Obese Mice
Amanda Machado, Janaína Ribeiro Oliveira, Deborah de F Lelis, et al.
Scientific Reports
|
October 24, 2023
Optimization of Plasmodium vivax infection of colonized Amazonian Anopheles darlingi
Alice O Andrade, Najara Akira C Santos, Alessandra S Bastos, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
February 10, 2022
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients
Bruno Gualano, Carla G S Saad, Sofia M Sieczkowska, et al.
Rheumatology (Oxford, England)
|
May 31, 2022
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine
Nadia E Aikawa, Leonard V K Kupa, Clovis A Silva, et al.
The Lancet. Rheumatology
|
December 13, 2021
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study
Nadia E Aikawa, Leonard V K Kupa, Sandra G Pasoto, et al.
Nature Medicine
|
July 31, 2021
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial
Ana C Medeiros-Ribeiro, Nadia E Aikawa, Carla G S Saad, et al.
Page
of 22